NRC Health Statistics
Total Valuation
NRC Health has a market cap or net worth of $383.05 million. The enterprise value is $458.53 million.
Important Dates
The last earnings date was Tuesday, April 28, 2026, after market close.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
NRC Health has 22.75 million shares outstanding. The number of shares has decreased by -5.81% in one year.
| Current Share Class | 22.75M |
| Shares Outstanding | 22.75M |
| Shares Change (YoY) | -5.81% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 46.42% |
| Owned by Institutions (%) | 48.95% |
| Float | 12.19M |
Valuation Ratios
The trailing PE ratio is 33.68.
| PE Ratio | 33.68 |
| Forward PE | n/a |
| PS Ratio | 2.76 |
| Forward PS | n/a |
| PB Ratio | 27.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.98 |
| P/OCF Ratio | 14.20 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.25, with an EV/FCF ratio of 26.31.
| EV / Earnings | 52.54 |
| EV / Sales | 3.31 |
| EV / EBITDA | 13.25 |
| EV / EBIT | 17.40 |
| EV / FCF | 26.31 |
Financial Position
The company has a current ratio of 0.52, with a Debt / Equity ratio of 5.78.
| Current Ratio | 0.52 |
| Quick Ratio | 0.35 |
| Debt / Equity | 5.78 |
| Debt / EBITDA | 2.22 |
| Debt / FCF | 4.48 |
| Interest Coverage | 5.15 |
Financial Efficiency
Return on equity (ROE) is 41.86% and return on invested capital (ROIC) is 18.34%.
| Return on Equity (ROE) | 41.86% |
| Return on Assets (ROA) | 12.21% |
| Return on Invested Capital (ROIC) | 18.34% |
| Return on Capital Employed (ROCE) | 27.42% |
| Weighted Average Cost of Capital (WACC) | 6.12% |
| Revenue Per Employee | $388,353 |
| Profits Per Employee | $24,445 |
| Employee Count | 357 |
| Asset Turnover | 1.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRC Health has paid $5.47 million in taxes.
| Income Tax | 5.47M |
| Effective Tax Rate | 37.69% |
Stock Price Statistics
The stock price has increased by +57.09% in the last 52 weeks. The beta is 0.41, so NRC Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +57.09% |
| 50-Day Moving Average | 16.02 |
| 200-Day Moving Average | 15.79 |
| Relative Strength Index (RSI) | 47.17 |
| Average Volume (20 Days) | 66,260 |
Short Selling Information
The latest short interest is 423,069, so 1.86% of the outstanding shares have been sold short.
| Short Interest | 423,069 |
| Short Previous Month | 435,239 |
| Short % of Shares Out | 1.86% |
| Short % of Float | 3.47% |
| Short Ratio (days to cover) | 5.23 |
Income Statement
In the last 12 months, NRC Health had revenue of $138.64 million and earned $8.73 million in profits. Earnings per share was $0.39.
| Revenue | 138.64M |
| Gross Profit | 85.68M |
| Operating Income | 26.35M |
| Pretax Income | 14.50M |
| Net Income | 8.73M |
| EBITDA | 34.60M |
| EBIT | 26.35M |
| Earnings Per Share (EPS) | $0.39 |
Full Income StatementBalance Sheet
The company has $2.55 million in cash and $78.03 million in debt, giving a net cash position of -$75.49 million or -$3.32 per share.
| Cash & Cash Equivalents | 2.55M |
| Total Debt | 78.03M |
| Net Cash | -75.49M |
| Net Cash Per Share | -$3.32 |
| Equity (Book Value) | 13.50M |
| Book Value Per Share | 0.60 |
| Working Capital | -18.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $26.98 million and capital expenditures -$9.55 million, giving a free cash flow of $17.43 million.
| Operating Cash Flow | 26.98M |
| Capital Expenditures | -9.55M |
| Depreciation & Amortization | 8.25M |
| Net Borrowing | 12.70M |
| Free Cash Flow | 17.43M |
| FCF Per Share | $0.77 |
Full Cash Flow StatementMargins
Gross margin is 61.80%, with operating and profit margins of 19.01% and 6.52%.
| Gross Margin | 61.80% |
| Operating Margin | 19.01% |
| Pretax Margin | 10.46% |
| Profit Margin | 6.52% |
| EBITDA Margin | 24.96% |
| EBIT Margin | 19.01% |
| FCF Margin | 12.57% |